Citation Impact
Citing Papers
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Ferroptosis: molecular mechanisms and health implications
2020 Standout
The Role of Phenolic Compounds in the Fight against Cancer – A Review
2013
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
The molecular machinery of regulated cell death
2019 Standout
Targeted therapies in bladder cancer: an overview of in vivo research
2015
Pim kinases in cancer: Diagnostic, prognostic and treatment opportunities
2012
HMGB1 in health and disease
2014
Bladder cancer
2016 Standout
Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma
2016
Can dicoumarol be used as a gonad-safe anticancer agent: anin vitroandin vivoexperimental study
2015
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Molecular Docking and Structure-Based Drug Design Strategies
2015 Standout
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
A Computational Model for Overcoming Drug Resistance Using Selective Dual-Inhibitors for Aurora Kinase A and Its T217D Variant
2013 StandoutNobel
Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancer
2013
Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA)
2018
Works of Sentai Ding being referenced
A potent chemotherapeutic strategy in prostate cancer: S-(methoxytrityl)-L-cysteine, a novel Eg5 inhibitor
2011
Dicoumarol enhances doxorubicin‐induced cytotoxicity in p53 wild‐type urothelial cancer cells through p38 activation
2009
High Mobility Group Box 1 Protein Is Methylated and Transported to Cytoplasm in Clear Cell Renal Cell Carcinoma
2013
Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma
2014
A Potent Chemotherapeutic Strategy for Bladder Cancer: (S)-Methoxy-Trityl-L-Cystein, a Novel Eg5 Inhibitor
2010
123 Anti-tumor activity of CXR1002, a novel anti-cancer clinical phase compound that induces ER stress and inhibits PIM kinases: Human tumor xenograft efficacy and in vitro mode of action
2010